Vanguard Group Inc Adma Biologics, Inc. Transaction History
Vanguard Group Inc
- $5.46 Trillion
- Q3 2024
A detailed history of Vanguard Group Inc transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 18,118,494 shares of ADMA stock, worth $321 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
18,118,494
Previous 14,516,652
24.81%
Holding current value
$321 Million
Previous $162 Million
123.17%
% of portfolio
0.01%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding ADMA
# of Institutions
319Shares Held
184MCall Options Held
917KPut Options Held
91.6K-
Black Rock Inc. New York, NY18.6MShares$330 Million0.0% of portfolio
-
State Street Corp Boston, MA13MShares$230 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA12.6MShares$224 Million0.05% of portfolio
-
Morgan Stanley New York, NY8.6MShares$152 Million0.01% of portfolio
-
Nuveen Asset Management, LLC Chicago, IL6.58MShares$117 Million0.04% of portfolio
About ADMA BIOLOGICS, INC.
- Ticker ADMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 196,356,992
- Market Cap $3.48B
- Description
- ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...